LAVISION BIOTEC GMBH

Their core work

LaVision BioTec is a German SME based in Bielefeld that designs and manufactures advanced optical microscopy systems for life science research, with particular expertise in light sheet fluorescence microscopy and multi-photon imaging. Their instruments allow researchers to capture three-dimensional images of biological tissues at high resolution, bridging instrument engineering and biomedical discovery. In H2020, they contributed their microscopy technology to a neuroscience training network studying brain barriers and, as a funded participant, applied super-resolution optical microscopy to nanosized pore dynamics in endothelial cells. They function primarily as a technology provider whose instruments enable other researchers to image biological structures that would otherwise be inaccessible.

What they specialise in

How they've shifted over time

In the earlier period (BtRAIN, 2015–2019), LaVision BioTec participated as a partner in a neuroscience-focused training network, contributing imaging expertise to brain barrier research without direct EC funding. By their second project (DeLIVER, 2018–2022), they became a funded participant in a more targeted study applying super-resolution microscopy to endothelial cell biology, indicating a shift from general imaging partnership toward active research roles in vascular biology. The trajectory suggests a company moving from instrument supplier contributing to large training consortia toward a research actor applying its own technology to specific biomedical problems.

LaVision BioTec appears to be transitioning from passive technology contributor in training networks toward active research participant applying super-resolution microscopy to specific vascular biology questions, making them an increasingly attractive partner for targeted biomedical imaging consortia.

How they like to work

LaVision BioTec has not led any H2020 project, participating either as a named partner or funded participant — consistent with a specialist technology company that contributes instruments and expertise rather than administrative coordination. Despite only two projects, they reached 32 distinct consortium partners across 13 countries, reflecting the large multi-institutional structure typical of MSCA-ITN training networks. This suggests they are comfortable operating as a specialist node within complex, multinational consortia rather than as a project hub.

32 unique consortium partners across 13 countries from just two projects — an unusually broad reach for an SME of this size, attributable to the large consortium structures of MSCA Innovative Training Networks. No single geographic cluster is identifiable from the available data.

What sets them apart

As a private SME that manufactures its own microscopy instruments, LaVision BioTec brings something most university labs and research institutes cannot: proprietary hardware expertise combined with direct participation in funded research. For a consortium needing super-resolution or light sheet microscopy capabilities, engaging LaVision BioTec means access to the people who engineered the instruments, not just users of off-the-shelf equipment. Their SME status also makes them a nimble, accessible partner compared to large instrument corporations, with more flexibility to tailor solutions to a specific research project's needs.

Highlights from their portfolio

• DeLIVER
  The only project with direct EC funding (EUR 249,216), it positions LaVision BioTec as an active research participant applying super-resolution optical microscopy to nanosized pore dynamics in endothelial cells — a highly specific and technically demanding application of their core instrument technology.
• BtRAIN
  An MSCA-ITN brain barriers training network that introduced LaVision BioTec to a large multinational consortium, establishing their profile as an imaging technology contributor in neuroscience-adjacent research before they moved into direct research participation.